The U.S. Food and Drug Administration has approved the marketing of a new tool to that can test a person’s blood to diagnose ...

Over the past decade, Ralph got involved with the Maine Running Club and began signing up for more road races. When he ...

The European Commission has approved Eisai and Biogen's Leqembi for a subset of patients with early-stage Alzheimer's disease, setting it up to become the first amyloid-targeting drug to reach the ...

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today welcomes investors, analysts and financial media to the company's Capital Markets Day.

The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China, and Japan gave a green light to ...

New dementia diagnoses have significantly decreased since 2015, a study published in BMJ found.But more people are living ...

A study of mice and people looks at how the brain takes an experience, like being cut off in traffic, and responds with an ...

More people in the U.S. South are prescribed a sought-after Alzheimer's-slowing drug compared to those in the Northeast, a ...